Causative pathogens of bacterial meningitis in children and their susceptibility to antibiotics

Internet Journal of Infectious Diseases

Volumn 9, Issue 1, 2010, Pages

  Namani, Sadie A ^a   Koci, Remzie A ^a   Dedushi, Kreshnike H ^a   Raka, Lul ^b  

^a UNIVERSITY CLINICAL CENTER OF KOSOVO   (Serbia)

^b National Institute of Public Health   (Serbia)

Author keywords

Bacterial meningitis; Neurological complications; Outcomes; Treatment

Indexed keywords

AMPICILLIN; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; PENICILLIN G; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; DRUG MEGADOSE; EPIDEMIC MENINGITIS; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PNEUMOCOCCAL MENINGITIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 79551544199     PISSN: None     EISSN: 15288366     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Meadow WL, Lantos J, Tanz RR, Mendez D, Unger R, Wallskog P. Ought 'standard care' be the 'standard of care'? A study of the time to administration of antibiotics in children with meningitis. Am J Dis Child 1993; 147:40.
2. Lin AL, Safdieh JE. The evaluation and management of bacterial meningitis: current practice and emerging developments. Neurologist 2010;16(3):143-51.
3. Tunkel AR, Scheld WM. Acute bacterial meningitis. Lancet 1995;346:1675-1680.
4. Tunkel AR, Scheld WM. Treatment of bacterial meningitis. Curr Infect Dis Rep 2002;4:7-16.
5. El Bashir H, Laundy M, Booy R. Diagnosis and treatment of bacterial meningitis. Arch Dis Child 2003; 88:615-620.
6. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-reistant pneumococcal meningitis. Lancet 1992; 339:405.
7. Hoffman O, Weber JR. Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord 2009;2:401-412.
8. Moon SY, Chung DR, Kim SW et al. Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea. Eur J Clin Microbiol Infect Dis 2010; 29 (7):793-800.
9. Tunkel AR. Bacterial Meningitis. Philadelphia: Lippincott, Williams and Wilkins; 2001.
10. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129: 862-869.
11. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990;162, 1316-23.
12. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Eng J Med 1993; 328, 21-8.
13. Bohr V, Hansen B, Jessen O, et al. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: clinical data, prognosis, and the role of specialised hospital departments. J Infect 1983; 7, 21-30.
14. Spanjaard L, Bol P, de Jong MC, Zanen HC. Bacterial meningitis in 366 children in the Netherlands, 1982-1983. Epidemiology and antibiotic therapy. J Antimicrob Chemother 1986; 54, 1-8.
15. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Eng J Med 1997; 336, 708-16.
16. Talan DA, Hoffman JR, Yoshikawa TT, Overturf GD. Role of empiric antibiotics prior to lumbar puncture in suspected bacterial meningitis: State of the art. Rev Infect Dis 1988; 10:365.
17. Luca V, Gessner BD, Luca C, et al. Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania. Eur J Clin Microbiol Infect Dis 2004; 23(7):523-8.
18. Ceyhan M, Yildirim I, Balmer P et al. Etiology of Childhood Acute Bacterial Meningitis, Turkey. Emerg Inf Dis 2008; 14(7):1089-1096.
19. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010;10(5):317-28.
20. Dery M, Hasbun R. Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep 2007;9:301-307.
21. Baraff LJ, Lee SI, Schriger DL. Outcomes for bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993; 12: 389-394.
22. Bryan CS, Reynolds KL, Crout L. Promptness of antibiotic therapy in acute bacterial meningitis. Ann Emerg Med 1986; 15:544-7.
23. Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. Br Med J 1992; 305:141-3.
24. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T.Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83:111-116.
25. Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 2001;21:387-392.
26. Lu CH, Huang CR, Chang WN, et al. Community-acquired bacterial meningitis in adults: The epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 2002;104:352-358.
27. Botha P. Penicillin-resistant Neisseria meningitidis in Southern Africa. Lancet 1998;8575:54.
28. Riley G, Brown S, Krishnan C. Penicillin resistance in Neisseria meningitidis. Lancet 1990; 324:997.
29. Rohner P, Pepey B, Hirschel B, Auckenthaler A. Typing and sensitivity of meningococci isolated in Switzerland 1988-1990. Schweiz Med Wochenschr 1992;122:224-228.
30. Saez-Neito JA, Fontanals D, Garcia de Jalon J, et al. Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations. Epidemiol Infect 1987; 99:463-469.
31. Sutcliffe EM, Jones MD, El-Sheikh S, Percival A. Penicillin-insensitive meningococci in the UK.Lancet 1998; 1(8586):657-658.
32. Tzanakaki G, Blackwell CC, Kremastinou J, Kallergi C, Kouppari G, Weir DM. Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece. Epidemiol Infect 1992;1108:449-455.
33. van Deuren M, Brandtzaeg P, van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13:144-166.
34. Boras A, Bozinovic D, Tenover FC, Popovic T. First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia. J Clin Microbiol 2001;39:823.
35. Punar M, Eraksoy H, Cagatay AA, et al. Neisseria meningitidis with decreased susceptibility to penicillin in Istanbul, Turkey. Scand J Infect Dis 2002;34:11-13.
36. Brown S, Riley G, Jamieson F. Neisseria meningitidis with decreased susceptibility to penicillin in Ontario, Canada 1997-2000. Can Commun Dis Rep 2001; 27:73-75.
37. Kaplan SL, Mason EO Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998;11:628-644.
38. Kaplan SL. Management of pneumococcal meningitis. Pediatr Infect Dis J 2002;21:589-591.